title: Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome.
abstract: BACKGROUND
  Polycystic ovary syndrome (PCOS) is characterized by chronic hyperandrogenic anovulation and is associated with insulin resistance. Its pathogenesis is believed to be multifactorial, and abnormal gene regulation could be one contributing factor. Type 5 17beta-hydroxysteroid dehydrogenase (17beta-HSD5) appears to be the major testosterone-forming 17beta-HSD isoenzyme in females.
  
  
  OBJECTIVE
  Our objective was to investigate the role of a potentially activating 17beta-HSD5 gene (HSD17B5) variant in hyperandrogenism.
  
  
  METHODS
  We conducted a case study and case-control cohort study in our General Clinical Research Center.
  
  
  METHODS
  Subjects included a case of PCOS who had hyperthecosis associated with profound type B insulin resistance and an unusual, frankly male testosterone response to a GnRH agonist test, as well as 121 PCOS patients and 128 population controls.
  
  
  METHODS
  Interventions were diagnostic.
  
  
  METHODS
  Main outcome measures included sequencing of HSD17B5 5'-flanking region and nine exons, genotype/phenotype studies, and in vitro functional studies.
  
  
  RESULTS
  Our case had a previously undescribed homozygous HSD17B5 variant (G-to-A substitution) -71 bp in the promoter region. Genotyping controls showed this to be a single-nucleotide polymorphism (SNP)-71G. Luciferase activity of a SNP-71G promoter construct was significantly higher than that of the wild type, and EMSAs revealed that SNP-71G possessed significantly increased affinity to nuclear transcription factors. SNP-71G allele frequency (32.2 vs. 22.3%) and SNP-71G allele presence (53.7% vs. 38.3%) were significantly increased in PCOS (P = 0.01) [corrected] SNP-71G homozygosity tended to contribute about 20% to the plasma testosterone level.
  
  
  CONCLUSIONS
  SNP-71G is a functional polymorphism that may contribute to testosterone excess in a subset of PCOS patients.
authors.affiliation: Department of Pediatrics, Section of Pediatric Endocrinology, The University of Chicago, Chicago, Illinois 60637, USA. kqin@peds.bsd.uchicago.edu
authors.forename: Kenan
authors.initials: K
authors.lastname: Qin
authors.forename: David A
authors.initials: DA
authors.lastname: Ehrmann
authors.forename: Nancy
authors.initials: N
authors.lastname: Cox
authors.forename: Samuel
authors.initials: S
authors.lastname: Refetoff
authors.forename: Robert L
authors.initials: RL
authors.lastname: Rosenfield
mesh_terms: D015067:17-Hydroxysteroid Dehydrogenases / Q000235:genetics*; D024202:Electrophoretic Mobility Shift Assay; D005260:Female; D017930:Genes, Reporter / Q000235:genetics; D005838:Genotype; D006801:Humans; D008156:Luciferases / Q000235:genetics; D011085:Polycystic Ovary Syndrome / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D011110:Polymorphism, Genetic / Q000235:genetics*; D012150:Polymorphism, Restriction Fragment Length; D013739:Testosterone / Q000097:blood; D014162:Transfection
chemical_list: D013739:Testosterone; D015067:17-Hydroxysteroid Dehydrogenases; D008156:Luciferases